Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your baby is between 0 and 90 days old and has not yet received a diagnosis
- Your baby shows signs or symptoms that doctors strongly suspect may be caused by a genetic condition
- Babies with a wide range of different symptoms or physical findings may be considered
Who may not be able to join:
- Babies whose prenatal blood screening test (NIPT) already showed a possible chromosome problem
- Babies whose amniocentesis results (fluid testing during pregnancy) came back abnormal
- Babies whose newborn screening test pointed to a problem with how their body processes nutrients or energy
- Babies who already had an abnormal FISH test result showing extra or missing chromosomes (such as trisomy 13, trisomy 18, or Turner syndrome)
- Babies already diagnosed with Down syndrome
- Babies who only have unusual physical features but no other birth differences or health problems
- Babies with a single, isolated birth difference (such as a spine opening, cleft lip or palate, heart wall defect, or diaphragm defect) on its own
- Babies whose birth differences are known to be caused by exposure to harmful substances during pregnancy (such as alcohol or certain medications like Isotretinoin)
- Babies whose birth differences are linked to the mother having diabetes during pregnancy
- Babies with a specific combination of birth differences known as VACTERL association (confirm with trial site)
- Babies who are medically unstable and need to be moved to a higher level of care
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brendan Lee, MD, PhD, Baylor College of Medicine
Phone: 281-224-0600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effectiveness of Consultagene
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.